ISPOR Russia HTA Chapter has been a co-organizer of the IV Scientific and Practical International Conference Health Technology Assessment: Value-Based Healthcare, which was held in Moscow, November 23rd, 2017.
Value-based healthcare is a healthcare delivery model that is focused on controlling outcomes important for patients and costs of treatment. By focusing on outcomes, value-based healthcare helps healthcare providers to manage costs and deliver improved medical care within limited financial resources.
The main goal of the event was to harmonize approaches for development of the healthcare system in Russia and concept of the value-based healthcare implementation in Russia. Number of adjacent topics also were discussed during the Conference, including increasing of cost efficiency on healthcare, development of quality criteria of medical care, information in healthcare, international experience of development of standard outcome measures. Presentations from international experts on value-based healthcare implementation experience from Sweden and Germany had a great success and brought a lot of discussions among the attendees of the event.
The representatives of the Federal Assembly of the Russian Federation, State Duma of the Russian Federation, Federal Compulsory Medical Insurance Fund, Ministry of Health and Ministry of Finance of the Russian Federation took part in the event. More than 400 participants attended the Conference. (Submitted by Russia HTA Chapter)
International Scientific and Practical Conference Health Technology Assessment Development in the Eurasian Economic Union, held on April 27-28, 2017 in Astana, Kazakhstan.
This Conference was devoted to issues of developing the health technology assessment (HTA) system and funding innovative and costly health technologies in the Eurasian Economic Union (EAEU) countries.
This event was aimed at consolidating HTA efforts in the EAEU, establishing an expert platform for determining further development route and prospects and possibilities for HTA integration in the EAEU countries as well as educating on basic HTA principles.
The conference was attended by leading EU and EAEU experts in HTA and drug provision as well as representatives of ministries of healthcare and medical insurance funds of the EAEU member countries.
The conference has been organized by ISPOR Russia HTA and ISPOR Kazakhstan Chapters; has been supported by the Ministry of Health and Social Development of Kazakhstan Republic, Board of the Eurasian Economic Commission, Ministry of Health of the Russian Federation, Financial Research Institute of the Ministry of Finance of the Russian Federation and Interparlamentary Assembly of the CIS Member Nations.
The conference took place in Hilton Garden Inn Astana, Astana, Kazakhstan.(Report from ISPOR Russia HTA Chapter).
ISPOR Russia HTA Chapter Activities at the Vienna Congress.
ISPOR 19th Annual European Congress in Vienna, Austria brought together under 5000 attendees from 89 countries of the world; congress featured nearly 2,500 presentations and included decision-makers, government officials, leading researchers and experts, academicians, students, pharmacists, public and private payers, HTA bodies, patients, patient advocates and many other stakeholders.
EMEA chapters showed great enthusiasm in organizing eminent meetings presenting interesting and urgent topics for the discussion, attracting numerous audience.
ISPOR Global Networks acknowledge a notable participation of ISPOR Russia HTA Chapter Activities at the Vienna Congress: CEE Network Executive and Working Committee meetings, CEE Network Reception, plenary sessions, poster and podium presentations, issue panels, etc.
ISPOR Russia HTA Chapter conducted a joint meeting discussing with the representatives of Kazakhstan, Russia St. Petersburg, Hungary, Armenia Chapters about the implementations of HTA in their countries. Many other exciting topics of great interest for all the attendees have been discussed.
The basics of healthcare system performance and quality of medical care enhancement are research, development, implementation and reasonable application of modern innovative technologies.
Implementation of innovative technologies and pharmaceutical leads to changes in approaches to disease mangement and in some cases significally improves outcomes and patients' quality of life. However, technological innovations are often associated with a significant increase in healthcare system costs.
International experience shows wider involvement of not only payers, healthcare experts and economists, but also representatives of industry, and the patients themselves in the negotiation process on the financing new technologies. Implementation of innovations in healthcare, unlike that in many other areas is directly related to the healthcare system's ability to make economically viable decisions and the development of the concept of HTA.
This event is supported by the Ministry of Health of Russia Federation, the Council of the Federation Committee on Social Policy of the Federal Assembly of the Russian Federation, Center of Healthcare quality Assessment a nd Control, Financial Research Institute of the Ministry of Finance of the Russian Federation, Autonomus Non-Profit organization National Center for HTA (ANO NCHTA) and the Skolkovo Foundation.
The conference is expected to be attended by European and BRICS countries' HTA agencies and EUnetHTA as well as by the local and international HTA and drug supply experts, etc.
The conference will focus on the following main topics: HTA development in russia, funding of healthcare in russia, early HTA and its influence on market accsess, funding on innovativs medical technologies, MCDA as a tool of measurement of innovativeness of medical technologies.
Conference venue: Renaissance Moscow Monarch Centre Hotel, Leningradsky Avenue, 31A/1, Moscow, Russia.
|President||Vitaly Omelianovskiy, MD, PhD, DSc, Professor|
|Vice President||Maria Avxentyeva, MD, PhD, DSc, Professor|
|Executive Director||George Khachatryan, MD|
Contact InformationISPOR Russia HTA Regional Chapter Office